For Ductal Carcinoma In Situ (DCIS), which is a non-invasive form of breast cancer, the risk of metastasis is generally low. However, the risk of recurrence or progression to invasive cancer can vary based on treatment choices and individual factors.

- Lumpectomy Alone: People who undergo a lumpectomy without radiation Show Full Answer

For Ductal Carcinoma In Situ (DCIS), which is a non-invasive form of breast cancer, the risk of metastasis is generally low. However, the risk of recurrence or progression to invasive cancer can vary based on treatment choices and individual factors.

- Lumpectomy Alone: People who undergo a lumpectomy without radiation have a higher chance of recurrence compared to those who also receive radiation therapy.
- Recurrence Rates: The chance of relapse for those who have a lumpectomy alone is about 25% to 30%.
- Follow-Up: Regular follow-up visits with a doctor are crucial to monitor for any signs of recurrence or progression.

While DCIS itself is unlikely to metastasize, if it progresses to invasive cancer, there is a potential risk for metastasis, including to the spine. Always consult with your healthcare provider for personalized advice and monitoring.

 This AI-generated response comes from MyBCTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Ductal Carcinoma In Situ (DCIS): Your Guide | MyBCTeam

What’s the Risk of Breast Cancer Recurrence After Mastectomy? 11 Symptoms To Watch For | MyBCTeam